Researchers have applied AI to every step of the drug development process. But this might not be enough to design safe and ...

Doctors have an overwhelming amount of individual patient data and medical research at their disposal to make diagnoses and ...

Tevogen Bio Holdings Inc. (“Company” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T-cell therapeutics for ...

The Food and Drug Administration (FDA) has recently released two draft guidance documents (Artificial Intelligence-Enabled Device Software ...

The initiative will build and power the infrastructure required to digitize and deliver impactful AI-driven pathology solutions to patients and caregivers.

Insilico Medicine (“Insilico ... s PandaOmics, the artificial intelligence-driven platform, to identify two novel therapeutic targets and a FDA approved drug as a potential repurposed ...

Kanavos Inc. has announced a strategic partnership with Graphwise, a global leader in semantic AI technologies, and HomeLab, a prominent biotech accelerator based at UC San Diego, to develop the ...

New documents clarify how the FDA plans to regulate AI-enabled devices, experts say, but several important questions remain ...

Business users could inadvertently face litigation, especially if they are aware that the training data might include unlicensed works or that an AI ... images of weapons and drugs, and much ...